|CVS Caremark to Participate in the Citi Investment Research 2010 Food & Drug Retail Conference|
WOONSOCKET, R.I., May 13, 2010 /PRNewswire via COMTEX/ --CVS Caremark Corporation (NYSE: CVS) today announced that members of its senior management team will be speaking to investors at the Citi Investment Research 2010 Food & Drug Retail Conference on May 25, 2010. Tom Ryan, Chairman and Chief Executive Officer, Larry Merlo, President and Chief Operating Officer, and David Denton, Executive Vice President and Chief Financial Officer, are scheduled to speak at approximately 12:30 p.m. ET.
An audio webcast of the presentation will be broadcast simultaneously through the Investor Relations portion of the CVS Caremark website for all interested parties. To access the webcast, visit http://info.cvscaremark.com/investors. This webcast will be archived and available on the web site for a 30-day period following the presentation.
About CVS Caremark
CVS Caremark is the largest pharmacy health care provider in the United States. Through our integrated offerings across the entire spectrum of pharmacy care, we are uniquely positioned to provide greater access, to engage plan members in behaviors that improve their health, and to lower overall health care costs for health plans, plan sponsors and their members. CVS Caremark is a market leader in mail order pharmacy, retail pharmacy, specialty pharmacy, and retail clinics, and is a leading provider of Medicare Part D Prescription Drug Plans. As one of the country's largest pharmacy benefits managers (PBMs), we provide access to a network of more than 64,000 pharmacies, including approximately 7,000 CVS/pharmacy(R) stores that provide unparalleled service and capabilities. Our clinical expertise includes one of the industry's most comprehensive disease management programs. General information about CVS Caremark is available through the Company's Web site at http://info.cvscaremark.com.
SOURCE CVS Caremark Corporation